HIA
ALXN

Harbor Investment Advisory’s Alexion Pharmaceuticals ALXN Stock Holding History

Harbor Investment Advisory’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-39
Closed -$7K – 1380
2021
Q2 		$7K Hold
39
– – ﹤0.01% 1074
2021
Q1 		$6K Sell
39
-680
-95% -$105K ﹤0.01% 1064
2020
Q4 		$112K Buy
719
+176
+32% +$22.6K 0.02% 429
2020
Q3 		$62K Buy
543
+259
+91% +$27.9K 0.01% 455
2020
Q2 		$32K Sell
284
-901
-76% -$95.7K 0.01% 528
2020
Q1 		$106K Sell
1,185
-151
-11% -$14.8K 0.03% 307
2019
Q4 		$144K Buy
+1,336
New +$143K 0.03% 295

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return